申请人:Pfizer Inc.
公开号:US05807867A1
公开(公告)日:1998-09-15
Compounds of the formula ##STR1## wherein R.sup.1 is methoxy and R.sup.2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
该公式的化合物为##STR1##,其中R.sup.1为甲氧基,R.sup.2为甲基、乙基、异丙基、仲丁基和叔丁基中的一种;以及这些化合物的药用盐。这些化合物是物质P拮抗剂,可用于治疗胃肠道疾病、炎症性疾病、中枢神经系统疾病和疼痛。